Post-stroke Epilepsy
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Anti-epileptogenic Effects of Eslicarbazepine Acetate (NCT06597084) | Bial - Portela C S.A. | 2019-05-29 |
| Post Stroke Epileptic Seizures Risk Forecast (NCT03848273) | Lviv National Medical University | 2019-02-20 |
Track Post-stroke Epilepsy automatically
Every clearance here is in the API, with alerts when new ones post.